Research Progress on the Correlation Between Epigenetics and Schizophrenia

Qing Chen, Dan Li, Weifeng Jin, Yun Shi, Zhenhua Li, Peijun Ma, Jiaqi Sun, Shuzi Chen, Ping Li, Ping LinFrontiers in Neuroscience 2021 · DOI

Abstract

Epigenetic modulations, including DNA methylation, ncRNA transcriptional regulation and histone modification, play an important role in the pathogenesis of schizophrenia. Therefore, tests of these epigenetic alterations may be utilized to assist in the diagnosis and determination of strategies of individualized treatment in clinical practice.

Introduction

Schizophrenia is a debilitating psychiatric disorder characterized by a complex, polygenic architecture. Rather than being caused by a single genetic defect, it arises from the interaction of numerous minor genetic variants and environmental stressors. Current diagnostic methods rely on clinical observations of symptoms like hallucinations and social withdrawal, which are inherently subjective. Consequently, there is an urgent need for objective biological markers. Epigenetics—the study of heritable changes in gene expression that do not alter the underlying DNA sequence—provides a vital link between genetic susceptibility and environmental triggers.

Methodology

This review synthesizes findings from a broad range of recent primary research, highlighting several high-throughput molecular biology techniques:

  • Epigenome Mapping: MassArray and Methylated DNA Immunoprecipitation (MeDIP-chip) are employed to map methylation patterns across the genome.
  • RNA Quantification: Droplet Digital PCR (ddPCR) and Next-Generation Sequencing (NGS) allow for high-precision quantification of rare RNA transcripts.
  • Tissue Analysis: Researchers examine post-mortem brain tissue (e.g., prefrontal cortex and hippocampus) to establish "ground truth" signatures, while peripheral blood analysis (PBMCs or plasma) is used to develop non-invasive clinical tests.

Key Epigenetic Mechanisms

DNA Methylation

A consistent finding in schizophrenia research is the hypermethylation of the RELN (reelin) and GAD1 promoters in the prefrontal cortex, which leads to the silencing of genes essential for neurotransmission. Notably, methylation levels of BDNF (Brain-Derived Neurotrophic Factor) in peripheral blood have been shown to reliably predict gene expression levels in the brain, validating the use of blood-based monitoring.

Non-coding RNAs (ncRNAs)

Non-coding RNAs, once considered "junk" DNA, are now recognized as critical regulators of gene expression.

MicroRNAs (miRNAs): miR-137 has emerged as a significant biomarker; its genotype strongly predicts earlier psychosis onset and reduced white matter integrity. Other miRNAs, such as miR-132 and miR-30e, show differential expression across various tissues.

Table 1: Differentially expressed microRNAs in schizophrenia across various sample types.

Long Non-coding RNAs (lncRNAs): Specific transcripts like FAS-AS1, Neat1, and Neat2 are significantly downregulated in the peripheral blood of patients. Machine learning models utilizing lncRNA data have achieved up to 96% predictive accuracy for schizophrenia diagnosis.

Table 2: Long non-coding RNAs (lncRNAs) dysregulated in schizophrenia.

Histone Modification

While less extensively studied than methylation, histone modifications such as increased acetylation at the promoters of GAD78 and HTR2C correlate directly with their expression levels in diseased states, indicating a role for chromatin remodeling in the disorder's pathology.

Clinical Insights and Future Directions

Epigenetic markers offer potential for personalized medicine. For example, OXTR methylation correlates with social symptoms specifically in females, while COMT methylation is a stronger risk predictor in males. Furthermore, antipsychotics like Clozapine and Olanzapine have been shown to shift methylation and miRNA levels, suggesting these molecules could serve as "readouts" for drug efficacy.

Despite this promise, challenges such as small sample sizes and the difficulty of establishing causality remain. Future research must prioritize longitudinal studies to track the "epigenetic trajectory" of schizophrenia from its earliest stages through treatment.

Summary updated

Abstract

Epigenetic modulations, including DNA methylation, ncRNA transcriptional regulation and histone modification, play an important role in the pathogenesis of schizophrenia. Therefore, tests of these epigenetic alterations may be utilized to assist in the diagnosis and determination of strategies of individualized treatment in clinical practice.
BibTeX
@inproceedings{chen2021research,
  author = {Qing Chen and Dan Li and Weifeng Jin and Yun Shi and Zhenhua Li and Peijun Ma and Jiaqi Sun and Shuzi Chen and Ping Li and Ping Lin},
  title = {{Research Progress on the Correlation Between Epigenetics and Schizophrenia}},
  booktitle = {Frontiers in Neuroscience},
  year = {2021},
  doi = {10.3389/fnins.2021.688727},
}
Figure